MYNZ

Mainz Biomed N.V.

0.95 USD
+0.05 (+5.46%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Mainz Biomed N.V. stock is down -6.86% since 30 days ago. The next earnings date is Sep 6, 2023. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 February’s closed higher than January.

About Mainz Biomed N.V.

Mainz Biomed B.V. develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. The company was founded in 2008 and is based in Mainz, Germany.